AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) drug wholesaler, is expected to report fourth quarter earnings results, before market open, on Thursday 5th November 2020.
Analysts polled by Thomson Reuters anticipate fourth quarter income of $ 1.85 per share.
Looking ahead, the full year income are expected at $ 7.87 per share on the revenues of $ 188638.00 million.
The Company Outlook
Full Year 2020 bottomline are predicted in a range of $ 7.80 ~ $ 7.95 per share
Click Here For More Historical Outlooks Of AmerisourceBergen Corporation (Holding Co)
Previous Quarter Performance
AmerisourceBergen Corporation (Holding Co) unveiled income for the third quarter of $ 1.85 per share, from the revenue of $ 45,367.00 million. The quarterly earnings escalated 5.11 percent while revenues expanded 0.28 percent compared with the same quarter last year.
Wall street analysts are predicting, ABC to report 3Q20 income of $ 1.56 per share from revenue of $ 44655.20 million. The bottom line results beat street analysts by $ 0.29 or 18.59 percent, at the same time, top line results outshined analysts by $ 711.80 million or 1.59 percent.
Stock Performance
Shares of AmerisourceBergen Corporation (Holding Co) traded up $ 2.84 or 2.78 percent on Wednesday, reaching $ 104.99 with volume of 1.70 million shares. AmerisourceBergen Corporation (Holding Co) has traded high as $ 107.37 and has cracked $ 102.78 on the downward trend
The closing price of $ 104.99, representing a 41.76 % increase from the 52 week low of $ 72.06 and a 4.86 % decrease over the 52 week high of $ 107.37.
The company has a market capital of $ 21.43 billion and is part of the Healthcare sector and Medical Distribution industry.
Recent Stock Dividend Announcement
The board of directors has authorized quarterly dividend of $ 0.42 per share on August 5, 2020. The dividend were payable on September 1, 2020 to holders of record as of the close of business on August 17, 2020 and ex-dividend date on August 14, 2020.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers.
